Literature DB >> 27244707

Concerns for Development After Bevacizumab Treatment of ROP.

Graham E Quinn1, Brian A Darlow2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27244707     DOI： 10.1542/peds.2016-0057

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  9 in total

1.  Plus Disease in Retinopathy of Prematurity: Diagnostic Trends in 2016 Versus 2007.

Authors:  Chace Moleta; J Peter Campbell; Jayashree Kalpathy-Cramer; R V Paul Chan; Susan Ostmo; Karyn Jonas; Michael F Chiang
Journal:  Am J Ophthalmol       Date:  2017-01-11       Impact factor: 5.258

2.  Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  David Morrison; James Shaffer; Gui-Shuang Ying; Gil Binenbaum
Journal:  J AAPOS       Date:  2018-03-14       Impact factor: 1.220

Review 3.  The neural retina in retinopathy of prematurity.

Authors:  Ronald M Hansen; Anne Moskowitz; James D Akula; Anne B Fulton
Journal:  Prog Retin Eye Res       Date:  2016-09-23       Impact factor: 21.198

Review 4.  Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity.

Authors:  Hao Tan; Patricia Blasco; Tamorah Lewis; Susan Ostmo; Michael F Chiang; John Peter Campbell
Journal:  Surv Ophthalmol       Date:  2021-03-02       Impact factor: 6.197

5.  EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.

Authors:  Huiqing Sun; Rui Cheng; Zhansheng Wang
Journal:  Retina       Date:  2020-06       Impact factor: 3.975

6.  Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors.

Authors:  Fatemeh Bazvand; Hamid Riazi-Esfahani; Ahmad Mirshahi; Alireza Khodabande; Hasan Khojastheh; Afsar Dastjani Farahani; Ramak Roohipourmoallai; Marjan Imani; Hooshang Faghihi; Nazanin Ebrahimi Adib; Mohammadreza Mehrabi Bahar
Journal:  Int J Retina Vitreous       Date:  2021-01-11

7.  Management of retinopathy of prematurity (ROP) in a Polish cohort of infants.

Authors:  Anna Chmielarz-Czarnocińska; Marta Pawlak; Dawid Szpecht; Aneta Choręziak; Marta Szymankiewicz-Bręborowicz; Anna Gotz-Więckowska
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

8.  Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity.

Authors:  David L Zhang; Hawke H Yoon; Raye-Ann O deRegnier; Jennifer Arzu; Safa Rahmani
Journal:  Clin Ophthalmol       Date:  2022-08-20

9.  Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.

Authors:  Gerard P Barry; Yinxi Yu; Gui-Shuang Ying; Lauren A Tomlinson; Juliann Lajoie; Marilyn Fisher; Gil Binenbaum
Journal:  Ophthalmology       Date:  2020-12-31       Impact factor: 14.277
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.